New York, NY, United States of America

Di Wu

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Children's Medical Center Corporation, American Express Travel Related Services Company, Inc., Pfizer Corporation. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Di Wu. Retrieved from https://idiyas.com/inventor/di-wu-ryblfqj9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • New York, NY (US) (2012)
  • Lexington, MA (US) (2023)

Company Filing History:


Years Active: 2012-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Di Wu - Innovator in Antibody Development

Introduction

Di Wu is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Di Wu holds a patent for "CD1a antibodies and uses thereof." This patent includes antibodies and antigen-binding fragments that specifically bind to Cluster of Differentiation 1a (CD1a). The embodiments of this patent encompass various uses and associated methods of utilizing these antibodies and fragments, highlighting their potential in therapeutic applications.

Career Highlights

Throughout his career, Di Wu has worked with prominent organizations, including Pfizer Corporation and Children's Medical Center Corporation. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the field of immunology.

Collaborations

Di Wu has collaborated with esteemed colleagues such as Florian E Winau and Oleg V Kovalenko. These partnerships have further enriched his research and innovation efforts, leading to advancements in antibody technology.

Conclusion

Di Wu's contributions to the field of antibody development exemplify the impact of innovation in medicine. His patent and collaborations reflect a commitment to advancing healthcare solutions through scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…